Business Context and Reporting Period
Company: Bond Laboratories, Inc. (trading as FITLIFE BRANDS, INC. in metadata, but filing identifies Bond Laboratories, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2008
Business Overview: The Company develops and markets fortified foods and beverages, focusing on energy drinks, pain relief, and weight loss. Its primary product is the "Fusion 6+ Hour Energy Shot," launched in late 2007. The Company contracts out manufacturing to maintain low overhead.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2008 | Six Months Ended June 30, 2008 |
|---|---|---|
| Revenue | $404,887 | $632,130 |
| Cost of Goods Sold | $387,561 | $537,397 |
| Gross Profit | $17,326 | $94,733 |
| Gross Margin | 4.3% | 15.0% |
| Operating Expenses | $1,698,306 | $2,858,462 |
| Net Loss | $(1,677,980) | $(2,754,208) |
| Cash and Equivalents (End of Period) | $2,549,867 | |
| Total Assets | $3,233,195 | |
| Total Liabilities | $32,145 | |
| Stockholders' Equity | $3,201,050 |
Liquidity: The Company reported a cash balance of approximately $2.55 million as of June 30, 2008, representing a significant increase from $590,197 at year-end 2007. Management states this provides over 18 months of working capital based on a monthly burn rate of approximately $125,000.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased dramatically from $532 in the three months ended June 30, 2007, to $404,887 in the same period in 2008. This reflects the commercial launch of the Fusion energy shot.
- Expense Surge: Selling and marketing expenses skyrocketed from $25,920 (3-month 2007) to $1,501,568 (3-month 2008). This includes significant advertising costs ($1.56 million for the six months) and stock-based compensation for sponsorships (680,000 shares valued at $1.00/share).
- Net Loss Expansion: Net loss widened from $(281,226) for the three months ended June 30, 2007, to $(1,677,980) for the same period in 2008, driven by aggressive marketing spend and operational scaling.
- Capital Raise: The Company raised approximately $3.5 million in equity during the six months ended June 30, 2008, compared to roughly $600,000 in the prior year period.
Guidance, Outlook, and Risks
Management Commentary: Management views the current losses as an investment in product development, packaging, and marketing required to establish market presence. They believe the "Fusion" product has a competitive advantage due to its concentrated format (2oz shot vs. 8-24oz cans) and lack of sugar/carbs.
Outlook: Future revenue is dependent on effective product introduction and securing contract manufacturing. The Company aims to replicate its business model in other markets.
Risks and Contingencies:
- Competition: The energy drink market is highly competitive with major players like Red Bull, Monster, and RockStar. The Company faces risks regarding market share and pricing pressure.
- Liquidity of Stock: Common stock trades on the OTC Bulletin Board and is subject to "penny stock" regulations, limiting liquidity and marketability.
- Key Personnel: Operations are heavily dependent on CEO Scott Landow; his loss would materially disrupt the business.
- Development Stage: The Company has a history of losses (accumulated deficit of $7.53 million) and has not yet achieved profitability.
Investor Verification Checklist
- Revenue Quality: Verify the collectibility of the $278,803 in accounts receivable, which represents a massive increase from $4,532 in the prior year.
- Marketing ROI: Assess the return on the $1.5 million+ in advertising and sponsorship expenses incurred in the first half of 2008 against the $632k revenue generated.
- Stock-Based Compensation: Confirm the valuation methodology for the 1.24 million shares issued to consultants in Q2 2008 and the 680,000 shares issued for sponsorships.
- Cash Burn Rate: Validate the management estimate of a $125,000 monthly cash requirement against actual operating cash flow usage of $1.28 million for the six-month period.
- Dilution: Review the impact of the 3.64 million shares issued for cash and the 1.8 million warrants outstanding on existing shareholder value.